Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 1999

Conditions

Glucosephosphate Dehydrogenase DeficiencyHyperbilirubinemiaHemolytic Disease of Newborn

Interventions

DRUG

tin mesoporphyrin

Trial Locations (2)

New England Medical Center Hospital, Boston

Rockefeller University Hospital, New York

All Listed Sponsors

collaborator

Rockefeller University

OTHER

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH